A clinician’s perspective: what tumor-organoid researchers ought to know
Organoid,
Journal Year:
2025,
Volume and Issue:
5, P. e1 - e1
Published: Jan. 25, 2025
Patient-derived
tumor
organoids
(PDTOs)
provide
powerful
platforms
for
modeling
human
tumors,
offering
insights
into
cancer
biology
and
personalized
therapy
development.
Incorporating
clinical
knowledge—such
as
staging,
molecular
profiling,
treatment
outcomes—enhances
the
relevance
of
PDTO
research.
Lung
staging
systems
guide
sample
selection,
thereby
influencing
organoid
growth
response
studies.
Clinical
endpoints
characteristics
further
align
experiments
with
real-world
therapeutic
challenges
patient
care.
Despite
their
potential,
research
faces
in
replicating
heterogeneity
microenvironment,
both
which
are
critical
studying
drug
resistance
efficacy.
Addressing
these
complexities
requires
close
collaboration
between
researchers
clinicians
to
ensure
that
models
accurately
reflect
course
disease.
This
review
provides
information
on
integrating
research,
focusing
aspects
such
endpoints,
implications
staging.
By
bridging
gap
basic
oncology,
aims
enhancing
translational
value
work.
A
clear
understanding
can
support
development
more
robust
models,
ultimately
advancing
strategies
improving
outcomes.
Language: Английский
Single-cell light-sheet fluorescence 3D images of tumour-stroma spheroid multicultures
Ákos Diósdi,
No information about this author
Filippo Piccinini,
No information about this author
Tímea Böröczky
No information about this author
et al.
Scientific Data,
Journal Year:
2025,
Volume and Issue:
12(1)
Published: March 24, 2025
Abstract
Spheroids
are
widely
used
in
oncology
for
testing
drugs,
but
models
composed
of
a
single
cell
line
do
not
fully
capture
the
complexity
vivo
tumours
targeted
by
chemotherapy.
Developing
3D
vitro
that
better
mimic
tumour
architecture
is
crucial
step
scientific
community.
To
enable
more
reliable
drug
testing,
we
generated
multiculture
spheroids
and
analysed
morphology
distribution
over
time.
This
dataset
first
publicly
available
single-cell
light-sheet
fluorescence
microscopy
image
collection
comprising
three
different
lines
at
time
points.
Specifically,
created
one
cancer
(melanoma,
breast
cancer,
or
osteosarcoma)
alongside
two
stromal
(fibroblasts
endothelial
cells).
Then,
acquired
resolution
images
to
analyse
spheroid
after
24,
48,
96
hours.
The
collection,
whole
annotations,
extracted
features
further
research
can
support
development
automated
analysis
models.
Language: Английский
Organoid-Immune Cell Co-culture for Stable Live Imaging
Nathalia Ferreira,
No information about this author
Frauke Alves,
No information about this author
M. Andrea Markus
No information about this author
et al.
Methods in molecular biology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 1, 2025
Language: Английский
The application of organoids in investigating immune evasion in the microenvironment of gastric cancer and screening novel drug candidates
Liuyue Kan,
No information about this author
Yingyan Yu,
No information about this author
Yan‐Jiang Wang
No information about this author
et al.
Molecular Cancer,
Journal Year:
2025,
Volume and Issue:
24(1)
Published: April 26, 2025
Gastric
cancer
(GC)
is
a
prevalent
digestive
system
tumor,
the
fifth
most
diagnosed
worldwide,
and
leading
cause
of
deaths.
GC
distinguished
by
its
pronounced
heterogeneity
dynamically
evolving
tumor
microenvironment
(TME).
The
lack
accurate
disease
models
complicates
understanding
mechanisms
impedes
discovery
novel
drugs.
A
growing
body
evidence
suggests
that
organoids,
developed
using
organoid
culture
technology,
preserve
genetic,
phenotypic,
behavioral
characteristics.
organoids
hold
significant
potential
for
predicting
treatment
responses
in
individual
patients.
This
review
provides
comprehensive
overview
current
clinical
strategies
GC,
as
well
history,
construction
applications
organoids.
focus
on
role
simulating
TME
to
explore
immune
evasion
intratumoral
microbiota
their
guiding
drug
therapy
facilitating
screening.
Furthermore,
we
summarize
limitations
underscore
need
continued
technological
advancements
benefit
both
basic
translational
oncological
research.
Language: Английский
Shrinking Cancer Research Barriers: Crafting Accessible Tumor‐on‐Chip Device for Gene Silencing Assays
Advanced Engineering Materials,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 5, 2024
Tumor‐on‐chip
(ToC)
is
crucial
to
bridge
the
gap
between
traditional
cell
culture
experiments
and
in
vivo
models,
allowing
recreate
an
vivo‐like
microenvironment
cancer
research.
ToC
use
microfluidics
provide
fine‐tune
control
over
environmental
factors,
high‐throughput
screening,
reduce
requirements
of
samples
reagents.
However,
creating
these
microfluidic
devices
requires
skilled
researchers
dedicated
manufacturing
equipment,
making
widespread
adoption
cumbersome
difficult.
To
address
some
bottlenecks
improve
accessibility
technology,
innovative
materials
fabrication
processes
are
required.
Polystyrene
(PS)
a
promising
material
for
due
its
biocompatibility,
affordability,
optical
transparency.
Herein,
process
based
on
direct
laser
writing
thermosensitive
PS,
swift
economical
crafting
with
easy
pattern
alterations,
presented.
For
first
time,
device
fabricated
only
by
PS
presented,
customizing
optimization
efficient
approaches.
These
biochips
support
2D
3D
cultures
comparable
viability
proliferation
kinetics
96‐well
plates.
The
data
show
that
gene
protein
silencing
efficiencies
remain
consistent
across
both
chip
plate‐based
cultures,
either
or
spheroid
format.
Although
simple,
this
approach
might
facilitate
customized
chip‐based
models.
Language: Английский
A multiparametric analysis including single-cell and subcellular feature assessment reveals differential behavior of spheroid cultures on distinct ultra-low attachment plate types
Frontiers in Bioengineering and Biotechnology,
Journal Year:
2024,
Volume and Issue:
12
Published: Aug. 2, 2024
Spheroids
have
become
principal
three-dimensional
models
to
study
cancer,
developmental
processes,
and
drug
efficacy.
Single-cell
analysis
techniques
emerged
as
ideal
tools
gauge
the
complexity
of
cellular
responses
in
these
models.
However,
single-cell
quantitative
assessment
based
on
3D-microscopic
data
subcellular
distribution
fluorescence
markers,
such
nuclear/cytoplasm
ratio
transcription
factors,
has
largely
remained
elusive.
For
spheroid
generation,
ultra-low
attachment
plates
are
noteworthy
due
their
simplicity,
compatibility
with
automation,
experimental
commercial
accessibility.
it
is
unknown
whether
what
degree
plate
type
impacts
formation
biology.
This
developed
a
novel
AI-based
pipeline
for
3D-confocal
optically
cleared
large
spheroids
at
wholemount,
single-cell,
sub-cellular
levels.
To
identify
relevant
samples
pipeline,
automated
brightfield
microscopy
was
employed
systematically
compare
size
eccentricity
formed
six
different
types
using
four
distinct
human
cell
lines.
showed
that
all
exhibited
similar
spheroid-forming
capabilities
gross
patterns
growth
or
shrinkage
during
4
days
after
seeding
were
comparable.
Yet,
varied
among
specific
lines
types.
Based
this
prescreen,
HaCaT
keratinocytes
HT-29
cancer
cells
further
assessed.
In
spheroids,
in-depth
revealed
correlation
between
size,
proliferation,
transcriptional
coactivator,
YAP1,
well
an
inverse
respect
differentiation.
These
findings,
yielded
model
level,
corroborate
earlier
concepts
role
YAP1
proliferation
differentiation
skin.
Further,
results
show
may
influence
outcome
campaigns
advisable
scan
optimal
configuration
investigation.
Language: Английский
Organoids research progress in gynecological cancers: a bibliometric analysis
Frontiers in Oncology,
Journal Year:
2024,
Volume and Issue:
14
Published: Oct. 28, 2024
Background
Gynecological
cancers
(GC)
pose
a
severe
threat
to
the
health
and
safety
of
women’s
lives,
organoids,
as
in-vitro
research
models,
have
demonstrated
significant
advantages
in
simulating
tissue
characteristics
drug
screening.
In
recent
years,
there
has
been
rapid
increase
outcomes
related
organoids
GC.
However,
no
bibliometric
study
concerning.
Methods
Publications
GC
from
2010-2023
were
retrieved
Web
Science
Core
Collection
(WoSCC).
We
conducted
analysis
visualization
using
CiteSpace,
VOSviewer,
Bibliometrix
R
Package.
This
included
spatiotemporal
distribution,
author,
sources,
references,
keywords.
Results
A
total
333
publications
included.
The
number
annual
indicated
an
explosive
phase
development
since
2019.
USA
was
most
important
country
terms
cooperation,
publication
output,
citation
centrality.
University
California
system
ranked
first
productivity
among
institutions,
HIPPO
Y
is
relevant
author
field.
CANCERS
published
documents,
NATURE
cited
sources.
Analysis
Keywords
References,
it
possible
establish
trend,
find
hotspots
Conclusion
delineated
global
landscapes
progress
trends
research.
emphasized
that
can
effectively
replicate
original
or
tumors,
providing
good
model
for
on
tumor-related
mechanisms
showing
screening
efficacy
clinical
prediction.
Additionally,
preclinical
they
provide
compelling
evidence
personalized
therapy
prediction
patient
responses.
Language: Английский
The new platform for cancer immunity research: Organoid systems
Ming Tian,
No information about this author
Qianchang Dennis Wang,
No information about this author
Tianyin Ma
No information about this author
et al.
Elsevier eBooks,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Jan. 1, 2024
Language: Английский
Advancements in 3D Cell Culture Models for Drug Discovery and Disease Modeling
Next frontier.,
Journal Year:
2024,
Volume and Issue:
8(1), P. 203 - 203
Published: Nov. 28, 2024
The
advent
of
3D
cell
culture
models
has
revolutionized
drug
discovery
and
disease
modeling,
offering
more
physiologically
relevant
systems
compared
to
traditional
2D
cultures.
These
advanced
mimic
the
in
vivo
microenvironment,
incorporating
critical
cellular
interactions,
extracellular
matrix
components,
gradients
oxygen
nutrients.
This
research
explores
development
application
technologies,
such
as
organoids,
spheroids,
bioprinted
tissues,
studying
mechanisms
evaluating
efficacy.
study
highlights
advantages
these
recapitulating
complex
biological
processes,
including
tumor
microenvironments,
organ
development,
tissue-specific
responses
therapeutic
agents.
By
employing
cutting-edge
techniques
microfluidics,
imaging,
computational
aims
optimize
for
high-throughput
screening
personalized
medicine.
findings
underscore
transformative
potential
bridging
gap
between
preclinical
studies
clinical
outcomes,
reducing
costs
improving
patient-specific
approaches.
Language: Английский